GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Shyndec Pharmaceutical Co Ltd (SHSE:600420) » Definitions » Beta

Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Beta : 1.13 (As of Apr. 07, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Shanghai Shyndec Pharmaceutical Co Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-04-07), Shanghai Shyndec Pharmaceutical Co's Beta is 1.13.


Shanghai Shyndec Pharmaceutical Co Beta Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Shyndec Pharmaceutical Co Beta Chart

Shanghai Shyndec Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 0.78 0.65 0.89 1.02

Shanghai Shyndec Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.93 1.07 1.03 1.02

Competitive Comparison of Shanghai Shyndec Pharmaceutical Co's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Shyndec Pharmaceutical Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shyndec Pharmaceutical Co's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Shyndec Pharmaceutical Co's Beta distribution charts can be found below:

* The bar in red indicates where Shanghai Shyndec Pharmaceutical Co's Beta falls into.


;
;

Shanghai Shyndec Pharmaceutical Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Shanghai Shyndec Pharmaceutical Co  (SHSE:600420) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Shanghai Shyndec Pharmaceutical Co Beta Related Terms

Thank you for viewing the detailed overview of Shanghai Shyndec Pharmaceutical Co's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shyndec Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1320 Beijinxi Road, Shanghai, CHN, 200040
Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.
Executives
Li Hao senior management
Ni Feng Director
Li Xian Lin senior management
Hao Chao Feng senior management
Lian Wan Yong Director
Han Yan Lin Director
Yang Wen Ming Supervisors
Feng Ming Director

Shanghai Shyndec Pharmaceutical Co Headlines

No Headlines